Source: Research Seminar 2004 - Genotyping and Phenotyping of Diffuse Parenchymal Lung Diseases
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Clement (Paris, France). Disease modifying genes: The cystic fibrosis lesson. Research Seminar 2004 - Genotyping and Phenotyping of Diffuse Parenchymal Lung Diseases

Member's Comments

No comment yet.

Related content which might interest you: Cystic fibrosis related pulmonary disease: more structure than function? Source: Eur Respir J 2005; 26: Suppl. 49, 729s Year: 2005 A new risk factor predicts ABPA in patients with cystic fibrosis Source: International Congress 2015 – Cystic fibrosis: assessment and treatment Year: 2015 Risk of asthma in heterozygous carriers for cystic fibrosis: A meta-analysis Source: International Congress 2016 – Cystic fibrosis: various aspects Year: 2016 Annual change of LCI among patients with cystic fibrosis Source: International Congress 2016 – Cystic fibrosis: monitoring and management Year: 2016 Monitoring early lung disease in cystic fibrosis: where are we now? Source: Breathe 2014; 10: 34-47 Year: 2014 Analysis of candidate genes of phenotypic expression in idiopathic pulmonary fibrosis Source: International Congress 2014 – ILDs 5 Year: 2014 Physical fitness in cystic fibrosis patients: What is the relation with airway obstruction? Source: International Congress 2015 – Cystic fibrosis: microbiology, immunology and assessment Year: 2015 Predicting five year outcomes in adults with cystic fibrosis: Developing a predictive scoring model Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults Year: 2013 Clinical value of lung clearance index (LCI) among patients with cystic fibrosis Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment Year: 2014 Sputum processing methods in airway disease: Which is best? Source: International Congress 2014 – Airway biomarkers Year: 2014 Disease progression in early idiopathic pulmonary fibrosis: Insights from the Australian IPF registry Source: International Congress 2016 – IPF: from pathogenesis to treatment II Year: 2016 Novel protein biomarkers of bronchiectasis in children with cystic fibrosis Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects Year: 2014 The role of CFTR/ENaC genotype in cystic fibrosis-like phenotypes Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects Year: 2014 MiR-214-3p, a new fibromiR involved in the pathogenesis of idiopathic pulmonary fibrosis Source: International Congress 2014 – Pathogenetic mechanisms in pulmonary fibrosis Year: 2014 Assessment of the work of breathing (sWOB) within different functional and genetic groups in patients with cystic fibrosis (CF) Source: Annual Congress 2013 –New perspectives of lung function assessment in children Year: 2013 How useful is the lung ultrasound in cystic fibrosis? Source: International Congress 2016 – Cystic fibrosis: various aspects Year: 2016 Cystic fibrosis: prospects for therapy of some class 1 mutations Source: Annual Congress 2007 - Cystic fibrosis: will the new biology deliver? Year: 2007 Lung inflammation in cystic fibrosis: an overlooked therapeutic target? Source: Virtual Congress 2020 – Cystic fibrosis: from cradle to old age Year: 2020 Pulmonary Disease in Pregnancy (Asthma, CF, TB etc.) Source: Respipedia Article Year: 2018